Experiences in Industrialised and Developing Countries
- New Horizons in the Economics of Innovation series
Chapter 3: From Human Insulin to Oncomice: Patterns of Innovation in Industrialised Countries
Page 32 3— From Human Insulin to Oncomice: Patterns of Innovation in Industrialised Countries 3.1— Introduction The establishment of biotechnology as a commercially viable set of techniques has taken place most rapidly in countries that are industrialised, i.e., in countries of North America, Europe and in Japan. The early commercialisation of biotechnology took place because of scientific breakthroughs in the 1970s and considerable risks taken by entrepreneurs and scientists to prove the viability of the new techniques. Once the potential of the technology was recognised, several governments put together national plans and policies to encourage and enable the commercialisation and diffusion of the new techniques. Patterns of innovation in biotechnology in industrialised countries, however, show considerable differences and gaps between countries. This chapter examines patterns of development of biotechnology in industrialised countries in order to determine the successes and failures of different development paths; and whether developing and industrialising countries still in the process of defining appropriate national priorities for biotechnology can learn valuable lessons from the experiences of industrialised countries. 3.2— Biotechnology Policies and Research in the Industrialised Countries The late 1970s and especially the early 1980s brought with them many changes relating to issues of technological change and its implications for Page 33 competitiveness in certain sectors. The apparent decline of traditional industries such as textiles and clothing was a result of the challenge from the newly industrialising countries of Asia and other developing countries and changing patterns of comparative advantage. Older, labour intensive industries became increasingly uncompetitive...
You are not authenticated to view the full text of this chapter or article.
Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.
Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.
Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.